Literature DB >> 2997701

The interaction of extracellular calcium with the platelet membrane glycoprotein IIb-IIIa complex.

S J Shattil, L F Brass.   

Abstract

Platelet aggregation requires the presence of extracellular Ca2+ and fibrinogen. When platelets are activated, fibrinogen receptors become expressed on the cell surface. These receptors are composed of a heterodimer complex of two integral membrane glycoproteins, IIb and IIIa. The requirement for Ca2+ in platelet aggregation can be explained in part by the interaction of Ca2+ with this complex. Conceptually, this interaction can be divided into three parts. First, Ca2+ holds the membrane IIb-IIIa complex together. Half-maximal dissociation of the complex occurs at 37 degrees in the presence of 0.4 uM extracellular Ca2. Mg2+ ions are unable to serve as a substitute for Ca2+. Second, studies with a complex-specific monoclonal antibody that binds only to activated platelets indicate that Ca2+ also is required for the agonist-induced conversion of the IIb-IIIa complex into a functional fibrinogen receptor. The KCa for receptor expression is also 0.4 uM, and Mg2+ is unable to substitute for the Ca2+. Third, Ca2+ is required for the actual binding of fibrinogen to its receptor. In this case, the KCa is 10-100 uM, and Mg2+ is an effective substitute for Ca2+. Thus, Ca2+ holds the IIb-IIIa complex together, is involved in fibrinogen receptor expression and supports fibrinogen binding. These multiple interactions of extracellular Ca2+ with glycoproteins IIb and IIIa help to explain the known requirement for Ca2+ in platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997701

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  4 in total

Review 1.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

Review 2.  Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.

Authors:  Ian C Gilchrist
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  The role of neuraminidase 1 and 2 in glycoprotein Ibα-mediated integrin αIIbβ3 activation.

Authors:  Dianne E van der Wal; April M Davis; Melanie Mach; Denese C Marks
Journal:  Haematologica       Date:  2019-07-04       Impact factor: 9.941

Review 4.  Platelet dysfunction after trauma: From mechanisms to targeted treatment.

Authors:  Pieter H Sloos; Paul Vulliamy; Cornelis van 't Veer; Anirban Sen Gupta; Matthew D Neal; Karim Brohi; Nicole P Juffermans; Derek J B Kleinveld
Journal:  Transfusion       Date:  2022-06-24       Impact factor: 3.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.